Skip to main content

Table 2 Characteristics of study participants on basis of kidney disease status

From: Prevalence and risk factors of kidney disease in urban Karachi: baseline findings from a community cohort study

 

No kidney disease

Mild kidney disease

Moderate kidney disease

Total cohort

p value

Age (years); Median (IQR)

30 (22–40)a

30 (19.75-54.25)b

52.5 (46–64.75)a,b,c

31 (22–43)

0.000**

n

292

30

28

350

BMI (kg/m2); Median (IQR)

21 (18.6-25.3)a

21.8 (18.5-27.4)b

23.9 (20.4-28.6)c

21.33 (18.64-25.5)

0.09

n

290

30

28

348

SBP (mmHg); Median (IQR)

118.7 (110.3-128.0)a

123.7 (109.6-130.0)b

133.0 (122.3-158.0)a,b,c

119.67 (110.67-129.67)

0.000**

n

291

30

28

349

DBP (mmHg); Median (IQR)

75.0 (69.0-82.3)a

77.5 (70.5-82.7)b

83.7 (73.9-96.4)a,c

75.7 (69.3-83.0)

0.004*

n

291

30

28

349

Creatinine (mg/dl); Median (IQR)

0.9 (0.8-1)a

0.9 (0.8-1.1)a,b

1.3 (1.12-1.48)a,c

0.9 (0.8-1.1)

0.000**

n

292

30

28

350

BSR (mg/dl); Median (IQR)

95 (87–106.25)a

98.5 (85.7-117.75)a,b

104.5 (91.5-141)a,c

96 (87–111)

0.03*

n

290

30

28

348

HBA1C (%); Median (IQR)

5.3 (4.8-5.8)a

5.8 (4.9-6.02)a,b

5.65 (4.82-6.07)a,c

5.4 (4.8-5.8)

0.03*

n

288

30

28

346

Total CL (mg/dl); Median (IQR)

155.5 (138–184)a

148.5 (128–177.25)b

164 (138.5-220.75)c

155 (137–184)

0.3

n

292

30

28

350

HDL (mg/dl); Median (IQR)

40 (35–45)a

37.5 (31.75-42)a,b

42 (37–45)a,c

40 (34–45)

0.03*

n

292

30

27

349

 
  1. a, b& cshows the significance difference between the groups. If any two or more groups have the same letters, there is significant difference between the groups.
  2. *p value < 0.05 and **p value < 0.0001, calculated using Kruskil Wallis test.
  3. IQR: Interquartile range (25th percentile – 75th percentile).